Antonio Tejera-Vaquerizo, Álvaro Gómez-Tomás, Ane Jaka, Agustín Toll, María Del Río, Carla Ferrándiz-Pulido, María J Fuente, Cristian Carrasco, Francisco M Almazán-Fernández, Tomás Toledo-Pastrana, Ada Ferrer-Fuertes, Simone Ribero, Gianluca Avallone, Javier Cañueto, Jorge Santos-Juanes, Onofre Sanmartín
BACKGROUND: The survival benefit of sentinel lymph node biopsy (SLNB) in immunocompetent and immunosuppressed patients with high-risk cutaneous squamous cell carcinoma (cSCC) has not been established. OBJECTIVE: To determine whether SLNB improves disease-specific survival (DSS) in high-risk cSCC. Secondary objectives were to analyse disease-free survival, nodal recurrence-free survival and overall survival (OS). METHODS: Multicentre, retrospective, observational cohort study comparing survival outcomes in immunosuppressed and immunocompetent patients treated with SLNB or watchful waiting...
May 13, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV